Follow
Cyxone AB
Nasdaq First North Sweden (Sweden)
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
CYXO
SE0007815428
Nasdaq First North Sweden
Sweden (SE)
Details of share in Cyxone AB with ticker CYXO
Status
Active
Order book id
Amount of instruments
49 080 380
Par value
0.0755
Market cap
Currency
SEK
Segment
First North
First trading date
07 Jun 2016
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
40M SEK
13 Apr - 29 Apr 2016
IPO in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
30 Jan - 10 Feb 2017
Option exercise terms for CYXO TO1
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
18 Sep - 29 Sep 2017
Option exercise terms for CYXO TO2
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
49.3M SEK
08 Oct - 23 Oct 2018
Share issue in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Exercise
5.37 SEK
228.87M SEK
02 Sep - 18 Sep 2019
Option exercise terms for CYXO TO3
Type
Price
Pre-money valuation
Time
Files
Directed issue
4.45 SEK
300M SEK
21 Jul 2020
Share issue in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Private placement
4.45 SEK
219.3M SEK
17 Sep 2020
Share issue in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Market move
2020
Listing of Cyxone AB on NASDAQ STOCKHOLM
Type
Ticker
ISIN
Market
SHARE
CYXO
SE0007815428
Nasdaq First North Sweden
Sweden (SE)
Details of share in Cyxone AB with ticker CYXO
Status
Active
Order book id
Amount of instruments
49 080 380
Par value
0.0755
Market cap
Currency
SEK
Segment
First North
First trading date
07 Jun 2016
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
40M SEK
13 Apr - 29 Apr 2016
IPO in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
49.3M SEK
08 Oct - 23 Oct 2018
Share issue in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Directed issue
4.45 SEK
300M SEK
21 Jul 2020
Share issue in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Private placement
4.45 SEK
219.3M SEK
17 Sep 2020
Share issue in Cyxone AB
Type
Price
Pre-money valuation
Time
Files
Market move
2020
Listing of Cyxone AB on NASDAQ STOCKHOLM
Type
Ticker
ISIN
Market
OPTION
CYXO TO1
SE0008268072
Nasdaq First North Sweden
Sweden (SE)
Details of option in Cyxone AB with ticker CYXO TO1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
Trading period
07 Jun 2016 - 08 Feb 2017
Terms
One (1) warrant TO1 entitle to subscribe one (1) new share in the Company.
Update (30.01.2017): Today, the subscription period for warrants of series TO 1 will commence.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
30 Jan - 10 Feb 2017
Option exercise terms for CYXO TO1
Type
Ticker
ISIN
Market
OPTION
CYXO TO2
SE0008268080
Nasdaq First North Sweden
Sweden (SE)
Details of option in Cyxone AB with ticker CYXO TO2
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
Trading period
07 Jun 2016 - 27 Sep 2017
Terms
One (1) warrant TO2 entitle to subscribe one (1) new share in the Company.
Update (18.09.2017): Today, the subscription period for subscription warrants of the TO 2 series commences.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
18 Sep - 29 Sep 2017
Option exercise terms for CYXO TO2
Type
Ticker
ISIN
Market
OPTION
CYXO TO3
SE0011751817
Nasdaq First North Sweden
Sweden (SE)
Details of option in Cyxone AB with ticker CYXO TO3
Status
Archived
Order book id
165516
Amount of instruments
17 735 034
Market cap
Currency
SEK
Segment
First North
Trading period
20 Dec 2018 - 16 Sep 2019
Terms
Each warrant entitles the holder to subscribe for one (1) new share in the Company. The subscription price amounts to the volume-weighted price of the Company's share during the period 19 August 2019 through August 30, 2019, with a discount of 25%, but not less than SEK 3.75 per share and a maximum of SEK 7.50 per share.
Update: The exercise price has been set to SEK 5.37.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.37 SEK
228.87M SEK
02 Sep - 18 Sep 2019
Option exercise terms for CYXO TO3
People
Number of Employees
3 people
Tara Heitner
CEO
Bert Roland Kari Junno
Chairman of the board
Bert Roland Kari Junno
Board member
Theresa Comiskey Olsen
Board member
Saad Urrehman Gilani
Board member
Mikael Lindstam
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Adelgatan 21
Zip code
211 22
City/district
Malmö
Country
Sweden (SE)
Registration number
559020-5471
LEI code
54930034OH16ROAY4K87
First trade date
07 Jun 2016
Registration date
13 Jul 2015
Short name
Cyxone

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date